Literature DB >> 32463918

Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity.

Stefano Caruso1, Daniel R O'Brien2, Sean P Cleary3, Lewis R Roberts4, Jessica Zucman-Rossi1,5.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32463918     DOI： 10.1002/hep.31394

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.298


× No keyword cloud information.
  21 in total

1.  Berberine Represses β-Catenin Translation Involving 4E-BPs in Hepatocellular Carcinoma Cells.

Authors:  Kanchan Vishnoi; Rong Ke; Karan S Saini; Navin Viswakarma; Rakesh Sathish Nair; Subhasis Das; Zhengjia Chen; Ajay Rana; Basabi Rana
Journal:  Mol Pharmacol       Date:  2020-10-31       Impact factor: 4.436

Review 2.  The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity.

Authors:  Stavros P Papadakos; Nikolaos Dedes; Elias Kouroumalis; Stamatios Theocharis
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

3.  Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway.

Authors:  Juncheng Guo; Min Guo; Jinfang Zheng
Journal:  Cancer Manag Res       Date:  2021-01-27       Impact factor: 3.989

4.  Ring finger protein 152-dependent degradation of TSPAN12 suppresses hepatocellular carcinoma progression.

Authors:  Jian Wan; Shunfang Liu; Wanju Sun; Haiyi Yu; Wenlian Tang; Wei Liu; Jing Ji; Bin Liu
Journal:  Cancer Cell Int       Date:  2021-02-18       Impact factor: 5.722

Review 5.  Innate immune cells and their interaction with T cells in hepatocellular carcinoma.

Authors:  Guo-Qing Hong; Dong Cai; Jian-Ping Gong; Xing Lai
Journal:  Oncol Lett       Date:  2020-11-19       Impact factor: 2.967

Review 6.  Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review.

Authors:  Nathália Alves Araújo de Almeida; Camilla Rodrigues de Almeida Ribeiro; Jéssica Vasques Raposo; Vanessa Salete de Paula
Journal:  Viruses       Date:  2021-05-02       Impact factor: 5.048

7.  Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions.

Authors:  Qiuxian Zheng; Qin Yang; Jiaming Zhou; Xinyu Gu; Haibo Zhou; Xuejun Dong; Haihong Zhu; Zhi Chen
Journal:  Cancer Cell Int       Date:  2021-06-30       Impact factor: 5.722

Review 8.  Autophagy in liver diseases: A review.

Authors:  Hui Qian; Xiaojuan Chao; Jessica Williams; Sam Fulte; Tiangang Li; Ling Yang; Wen-Xing Ding
Journal:  Mol Aspects Med       Date:  2021-06-11

9.  Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma.

Authors:  Xiaofei Wang; Jie Qiao; Rongqi Wang
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

10.  Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma.

Authors:  Haijing Deng; Anna Kan; Ning Lyu; Meng He; Xin Huang; Shuang Qiao; Shaolong Li; Wenhua Lu; Qiankun Xie; Huiming Chen; Jinfa Lai; Qifeng Chen; Xiongying Jiang; Shousheng Liu; Zhenfeng Zhang; Ming Zhao
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.